Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection

Show other versions (1)

Bibliographic Details
Main Authors:	Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T
Format:	Journal article
Published:	2012

Similar Items

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
by: Archary, D, et al.
Published: (2012)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
by: Archary, Derseree, et al.
Published: (2014)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
by: Archary, D, et al.
Published: (2012)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
by: Archary D, et al.
Published: (2012-09-01)

HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression.
by: Archary, D, et al.
Published: (2010)

HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
by: Goulder Philip JR, et al.
Published: (2010-11-01)

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
by: Murphy, M, et al.
Published: (2013)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
by: Murphy MK, et al.
Published: (2012-09-01)

Heterologous neutralization breadth persists despite B-lymphocyte dysfunction in chronic HIV-1 infection
by: Murphy MK, et al.
Published: (2012-09-01)

Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
by: Wright, J, et al.
Published: (2009)

Comparison of the neutralization sensitivity of South African and Indian HIV-1 subtype C viruses to South African plasma antibodies
by: Hermanus T, et al.
Published: (2012-09-01)

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
by: Megan K Murphy, et al.
Published: (2013-02-01)

Inhibition of HIV-1 subtype C by 2’F-RNA aptamers isolated against enveloped pseudovirus
by: London GG, et al.
Published: (2012-09-01)

Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection
by: M. Muenchhoff, et al.
Published: (2020-12-01)

P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
by: Wright, J, et al.
Published: (2009)

P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
by: Goulder PJ, et al.
Published: (2009-10-01)

Revisiting the Influence of HLA-type, Frequency, HLA-supertype and Homozygosity on the Immune Control of HIV
by: Leslie, A, et al.
Published: (2008)

Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies
by: Jenniffer M. Mabuka, et al.
Published: (2017-09-01)

Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
by: Rolland, M, et al.
Published: (2010)

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.
by: Penny L Moore, et al.
Published: (2009-09-01)

P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization
by: Abdool-Karim S, et al.
Published: (2009-10-01)

Harnessing the protective potential of HIV-1 neutralizing antibodies [version 1; referees: 2 approved]
by: S Abigail Smith, et al.
Published: (2016-01-01)

Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.
by: Leslie, A, et al.
Published: (2010)

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms
by: Amyn A. Murji, et al.
Published: (2021-07-01)

Limited Sequence Variation and Similar Phenotypic Characteristics of HIV-1 Subtype C Gag Variants Derived From the Reservoir and Pre-Therapy Plasma
by: Doty Ojwach, et al.
Published: (2022-07-01)

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains
by: Narayanaiah Cheedarla, et al.
Published: (2018-03-01)

Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics
by: Brander, Christian, et al.
Published: (2011)

Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
by: Morgane Rolland, et al.
Published: (2010-09-01)

Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.
by: Ndhlovu, Z, et al.
Published: (2011)

Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection
by: Madeleine F. Jennewein, et al.
Published: (2020-08-01)

HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
by: Basu Debby, et al.
Published: (2012-09-01)

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.
by: Rong Rong, et al.
Published: (2009-09-01)

Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.
by: Hannah O Ajoge, et al.
Published: (2011-01-01)

Nef genotype influences immune control in individuals living with HIV-1 who carrying protective alleles
by: F. Method Mwimanzi, et al.
Published: (2019-07-01)

Tuberculous meningitis is associated with higher cerebrospinal HIV-1 viral loads compared to other HIV-1-associated meningitides.
by: Ikanyeng D Seipone, et al.
Published: (2018-01-01)

PP 3.14 – 00190 Ex vivo response to latency reversal agents of CD4+ T cell subsets and monocyte derived HIV-1 subtype C LTR from individuals on suppressive cART
by: K. Gopee, et al.
Published: (2022-12-01)

Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.
by: Wright, J, et al.
Published: (2011)

Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B.
by: Elin Solomonovna Gray, et al.
Published: (2006-07-01)

PP 3.7 – 00128 Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes
by: P. Madlala, et al.
Published: (2022-12-01)

Spatial accessibility and the spread of HIV-1 subtypes and recombinants.
by: Tatem, A, et al.
Published: (2012)